National database for infective endocarditis in France

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observatory aims to create a comprehensive national database for infective endocarditis by collecting standardized data from various volunteer centers across France. It will gather clinical, biological, microbiological, and therapeutic information about patients diagnosed with infective endocarditis during their hospitalization. The study will analyze risk factors, prognosis, management practices, and treatment strategies, including antibiotic and surgical interventions. Data will be recorded using electronic case report forms to ensure consistency and accuracy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Major Patient
* Supported in one of the participating centers
* The application of diagnostic classification criteria of Duke modified by Li is carried out after collection of all the data at the end of the patient's hospitalization. Only patients meeting criteria for definite or possible endocarditis will be included in the analyses.
* Registered with the French social security system

Exclusion Criteria:

• Refusal of the patient to participate.

Where it's running

• Chru
  Vandœuvre-lès-Nancy, France Recruiting

Study contacts

• Principal investigator: Christine SELTON-SUTY, MD — CHRU Nancy
• Study coordinator: Nadine JUGE, PhD
• Email: n.juge@chru-nancy.fr

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Al[18F]F-NOTA-folate PET imaging in suspected cardiac sarcoidosis and infective endocarditis

  This diagnostic test uses a folate-based PET tracer to see if it can help identify inflammation or infection in the heart for people with suspected cardiac sarcoidosis or infective endocarditis.

  Recruiting Turku University Hospital · Turku · NCT07814222

• Etiologic Diagnosis Algorithm in Infective Endocarditis

  Aiming to see if a combined culture and molecular testing approach can help doctors choose the right antibiotics faster for adults with infective endocarditis.

  Recruiting at 2 sites I.M. Sechenov First Moscow State Medical University · Moscow and 2 other locations · NCT07682389

• Rifampin-free therapy vs rifampin-containing therapy for staphylococcal prosthetic valve endocarditis

  This study tests whether a rifampin-free antibiotic regimen can be as effective as a rifampin-containing regimen for adults with staphylococcal prosthetic valve endocarditis.

  Recruiting at 29 sites Phase 3 Nantes University Hospital · Aix-les-Bains and 30 other locations · NCT07345325

• Improving health and quality of life for patients recovering from infective endocarditis through cardiac rehabilitation

  This study is testing if joining a cardiac rehabilitation program can help people recovering from infective endocarditis feel healthier and improve their quality of life.

  Recruiting Region Halland · Halmstad, Halland County · NCT06704048

• Echocardiography versus no echocardiography for Staphylococcus aureus bloodstream infection with VIRSTA score <3

  This trial tests whether it is safe to skip routine echocardiography in adults hospitalized with Staphylococcus aureus bloodstream infection who have a VIRSTA score under 3.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT06457386

• Barts Endocarditis Registry

  This registry collects health, imaging, microbiology, treatment, and outcome information from adults with infective endocarditis seen at Barts Heart Centre to learn which approaches work best.

  Recruiting Queen Mary University of London · London · NCT06434012

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.